In all cases, voriconazole was the suspected drug; however, in 5 cases, voriconazole had been administered with another drug (morphine, cytarabine, ciprofloxacin, imatinib, acetaminophen ...

Altogether, 108 patients had voriconazole TDM performed (Table 1) between 2007 and 2009. Fifty-nine (54.6%) of patients were male. Eighty-five (78.7%) were white, seven (6.5%) were Asian ...

The company’s drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF ...

Such infections can end up spreading to other parts of the body as well. An anti-fungal agent named voriconazole is typically the treatment of choice for these infections. Other options include ...

TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large ...

Ethynodiol diacetate 1mg, ethinyl estradiol 35micrograms, 21 tabs; inert (7 tabs). See Contraindications. ALT elevations with HCV regimen ombitasvir/paritaprevir ...